Td Ameritrade Investment Management, LLC Neurocrine Biosciences Inc Transaction History

Td Ameritrade Investment Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$94.02 - $117.1 $6,957 - $8,665	-74 Closed	0 $0
Q2 2023 Aug 09, 2023	SELL	$89.53 - $104.87 $2,954 - $3,460	-33 Reduced 30.84%	74 $7,000
Q1 2023 May 15, 2023	SELL	$94.11 - $123.02 $4,046 - $5,289	-43 Reduced 28.67%	107 $11,000
Q4 2022 Feb 09, 2023	BUY	$106.72 - $127.06 $16,008 - $19,059	150 New	150 $18,000
Q2 2022 Aug 09, 2022	SELL	$75.79 - $100.07 $14,324 - $18,913	-189 Reduced 38.26%	305 $30,000

Q1 2022 May 16, 2022	SELL	$72.45 - $94.81 $2,753 - $3,602	-38 Reduced 7.14%	494 $46,000
Q4 2021 Feb 11, 2022	BUY	$79.65 - $106.22 $42,373 - $56,509	532 New	532 $45,000

628

94.4M

505K

343K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13.2B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Td Ameritrade Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Td Ameritrade Investment Management, LLC with notifications on news.